product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Zyxin (Ser142/143) Antibody
catalog :
4863
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 2
Reference
Han X, Li P, Yang Z, Huang X, Wei G, Sun Y, et al. Zyxin regulates endothelial von Willebrand factor secretion by reorganizing actin filaments around exocytic granules. Nat Commun. 2017;8:14639 pubmed publisher
Hoffman L, Jensen C, Chaturvedi A, Yoshigi M, Beckerle M. Stretch-induced actin remodeling requires targeting of zyxin to stress fibers and recruitment of actin regulators. Mol Biol Cell. 2012;23:1846-59 pubmed publisher
product information
SKU :
4863S
Product-Name :
Phospho-Zyxin (Ser142/143) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, Mk
Applications :
Western blot
Product-Category :
Adhesion/ECM
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
78
Host :
Rabbit
Target :
zyxin (Ser142/Ser143) phosphate
Primary-Protein :
zyxin
Alt-Names :
ESP-2,HED-2,ZYX,Zyxin,Zyxin-2
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.